Top Markets
#1 GEKKO GEKKO +50.71%
#2 Helium Helium +45.05%
#3 TENDIES TENDIES +44.18%
#4 ADO Protocol ADO Protocol +39.08%
#5 Pons Pons +36.21%
#6 Prom Prom +32.22%
#7 o1.exchange o1.exchange +21.80%
#8 StonkBroker StonkBroker +21.46%
#9 Collector Crypt Collector Crypt +20.52%
#10 Nillion Nillion +19.37%
Coin of the day
GEKKO GEKKO
Settings
Language
ENGLISH
Currency
USD
Theme
Vetoquinol S.A. Vetoquinol S.A.

Vetoquinol S.A.

VETO
Rank in Stocks #9672
Vetoquinol S.A. is a prominent veterinary pharmaceutical enterprise dedicated... Vetoquinol S.A. is a prominent veterinary pharmaceutical enterprise dedicated to the innovation, development, and global commercialization of both medicinal and non-medicinal solutions for animal health. Its operations extend across Europe, the Americas, and the Asia Pacific regions. The company's diverse product portfolio addresses crucial therapeutic areas, including mobility, pain management, and inflammation; dermatological care and hygiene; anti-parasitic treatments; udder health; infectious disease control; reproductive solutions; behavior modification; internal medicine; and cardiovascular-renal support. These offerings cater to a wide spectrum of animals, encompassing livestock such as cattle, sheep, pigs, and poultry, alongside companion animals like dogs. Founded in 1933, Vetoquinol S.A. is headquartered in Lure, France, and functions as a subsidiary of Soparfin SCA.
Share Price
$83.27
Last synced: 2026-08-28
Market Cap
$967.96M
Change (1 day)
-0.85%
Change (1 year)
-5.99%
Country
FR
Trade Vetoquinol S.A. (VETO)

Category

Healthcare
Revenue for Vetoquinol S.A. (VETO)
Revenue in Aug 2026 TTM: 0
According to Vetoquinol S.A. latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Vetoquinol S.A. from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
MERCK Kommanditgesellschaft auf Aktien MERCK Kommanditgesellschaft auf Aktien
MERCK Kommanditgesellschaft auf Aktien
MER.SW
 - -
DE
Merck KGaA Merck KGaA
Merck KGaA
MRK.DE
 - -
DE
Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
4502.T
 - -
JP
Galderma Group AG Galderma Group AG
Galderma Group AG
GALD.SW
 - -
CH
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
SUNPHARMA.NS
 $6.61B -
IN